ACT Capital Partners »

Uipath Inc Cl A shares owned by ACT Capital Partners

Quarter-by-quarter ownership of Uipath Inc Cl A (PATH) shares owned by ACT Capital Partners from 13F filings

Historical chart of ACT Capital Partners investment in Uipath Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Uipath Inc Cl A held by ACT Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Uipath Inc Cl A by ACT Capital Partners

Quarter filed Position value Share count Share price at filing
2026-09-30 $347k 27k 12.84

More positions owned by ACT Capital Partners

Chevron Corporation (CVX)
Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Exxonmobil Holdings Corp Com Shs (XOM)
Amazon (AMZN)
Abivax Sa Sponsored Ads (ABVX)
Viking Therapeutics (VKTX)
Sk Hynix American Deposit (SKHY)
Arrowhead Pharmaceuticals (ARWR)
Nektar Therapeutics Com New (NKTR)
Tesla Motors (TSLA)
Celcuity (CELC)
Micron Technology (MU)
Nuvation Bio Com Cl A (NUVB)
Palvella Therapeutics Inc Ne (PVLA)

View all positions for ACT Capital Partners

Top funds holding Uipath Inc Cl A

BlackRock
Polygon Management
Vanguard Portfolio Management
Vanguard Capital Management
Two Sigma Investments
State Street Corporation
Susquehanna International
Goldman Sachs Group
Rima Management
Bank of America Corporation
UBS Group
Jane Street
Dimensional Fund Advisors
Geode Capital Management
Citadel Advisors

View all funds holding Uipath Inc Cl A